Correction

Published on 05 Jan 2023

Corrigendum: Compounds purified from edible fungi fight against chronic inflammation through oxidative stress regulation

in Inflammation Pharmacology

Yidan Xia
Dongxu Wang
Jiaqi Li
Minqi Chen
Duo Wang
Ziping Jiang
Bin Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1081523

1,013 views

Review

Published on 04 Jan 2023

Research progress of nano selenium in the treatment of oxidative stress injury during hepatic ischemia-reperfusion injury

in Inflammation Pharmacology

Xin Deng
Peng Ouyang
Wei Xu
Erhua Yang
Zhen Bao
Yijing Wu
Jin Gong
Jinghua Pan

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1103483

2,480 views
7 citations

Editorial

Published on 04 Jan 2023

Editorial: Recent advances in novel therapeutic molecules and targets for inflammatory diseases

in Inflammation Pharmacology

Feng Li
Shaogui Wang
Xiaojuan Chao
Shuai Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1121821

1,858 views
2 citations

Editorial

Published on 04 Jan 2023

Editorial: Inflammation and aging in chronic and degenerative diseases: Current and future therapeutic strategies

in Inflammation Pharmacology

Luca Falzone
Saverio Candido
Anca Oana Docea
Daniela Calina

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1122786

1,557 views
4 citations

Original Research

Published on 23 Dec 2022

Morroniside ameliorates inflammatory skeletal muscle atrophy via inhibiting canonical and non-canonical NF-κB and regulating protein synthesis/degradation

in Inflammation Pharmacology

Xiangjiao Yi
Jianguo Tao
Yu Qian
Feng Feng
Xueqin Hu
Taotao Xu
Hongting Jin
Hongfeng Ruan
Hou-Feng Zheng
Peijian Tong

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1056460

5,796 views
12 citations

Original Research

Published on 23 Dec 2022

Lonicerin attenuates house dust mite-induced eosinophilic asthma through targeting Src/EGFR signaling

in Inflammation Pharmacology

Zhenan Deng
Xuefei Zhang
Junjie Wen
Xiaojing Yang
Lingna Xue
Changxing Ou
Jianjuan Ma
Hongrui Zhan
Xiaomin Cen
Xuliang Cai

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1051344

4,009 views
6 citations

Review

Published on 22 Dec 2022

Immunotherapy strategies and prospects for acute lung injury: Focus on immune cells and cytokines

in Inflammation Pharmacology

Wenfang Zhu
Yiwen Zhang
Yinghong Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1103309

4,995 views
14 citations

Review

Published on 22 Dec 2022

Activation of cancer immunotherapy by nanomedicine

in Inflammation Pharmacology

Lijuan Wang
Henan Xu
Lili Weng
Jin Sun
Ye Jin
Chunping Xiao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1041073

3,899 views
6 citations

Original Research

Published on 16 Dec 2022

Fenofibrate suppresses corneal neovascularization by regulating lipid metabolism through PPARα signaling pathway

in Inflammation Pharmacology

Tong Zhou
Ke Yan
Yuhan Zhang
Linfangzi Zhu
Yi Liao
Xiaoxiang Zheng
Yongxiong Chen
Xiaoxin Li
Zuguo Liu
Zhaoqiang Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1000254

4,101 views
4 citations

Original Research

Published on 16 Dec 2022

Risk factors for diabetic foot ulcers mortality and novel negative pressure combined with platelet-rich plasma therapy in the treatment of diabetic foot ulcers

in Inflammation Pharmacology

Yanling Wang
Bang Liu
Yinzhen Pi
Li Hu
Yeling Yuan
Jiao Luo
Yixiao Tao
Ping Li
Shan Lu
Wei Song

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1051299

4,138 views
5 citations

Mini Review

Published on 16 Dec 2022

Nanotechnology in cervical cancer immunotherapy: Therapeutic vaccines and adoptive cell therapy

in Inflammation Pharmacology

Xuyan Zhou
Haiying Lian
Hongpeng Li
Meiling Fan
Wei Xu
Ye Jin

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1065793

5,081 views
10 citations

Original Research

Published on 16 Dec 2022

C188-9, a specific inhibitor of STAT3 signaling, prevents thermal burn-induced skeletal muscle wasting in mice

in Inflammation Pharmacology

Yuko Ono
Masafumi Saito
Kazuho Sakamoto
Yuko Maejima
Shingen Misaka
Kenju Shimomura
Nobuto Nakanishi
Shigeaki Inoue
Joji Kotani

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1031906

3,537 views
9 citations

Review

Published on 16 Dec 2022

The emerging roles of TLR and cGAS signaling in tumorigenesis and progression of ovarian cancer

in Inflammation Pharmacology

Zhen Zhang
Hong Zhao
Chu Chu
Xiaoxiao Fu
Yonglin Liu
Li Wang
Ran Wei
Ke Xu
Lihua Li
Xia Li

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1072670

2,157 views
3 citations

Editorial

Published on 15 Dec 2022

Editorial: Purinergic signaling and neuroinflammation

in Inflammation Pharmacology

Charles Elias Assmann
Savina Apolloni
Zuleide Maria Ignácio
Margarete Dulce Bagatini

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1113063

1,092 views

Review

Published on 15 Dec 2022

A review of recent advances in exosomes and allergic rhinitis

in Inflammation Pharmacology

Zhong Zheng
Yangyang Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1096984

4,338 views
9 citations

Review

Published on 14 Dec 2022

The significance of glycolysis in tumor progression and its relationship with the tumor microenvironment

in Inflammation Pharmacology

Daoying Zhou
Zhen Duan
Zhenyu Li
Fangfang Ge
Ran Wei
Lingsuo Kong

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1091779

13,767 views
55 citations

Navigation group

Articles

Corrigendum: Compounds purified from edible fungi fight against chronic inflammation through oxidative stress regulation

Research progress of nano selenium in the treatment of oxidative stress injury during hepatic ischemia-reperfusion injury

Editorial: Recent advances in novel therapeutic molecules and targets for inflammatory diseases

Editorial: Inflammation and aging in chronic and degenerative diseases: Current and future therapeutic strategies

Morroniside ameliorates inflammatory skeletal muscle atrophy via inhibiting canonical and non-canonical NF-κB and regulating protein synthesis/degradation

Lonicerin attenuates house dust mite-induced eosinophilic asthma through targeting Src/EGFR signaling

Immunotherapy strategies and prospects for acute lung injury: Focus on immune cells and cytokines

Activation of cancer immunotherapy by nanomedicine

Fenofibrate suppresses corneal neovascularization by regulating lipid metabolism through PPARα signaling pathway

Risk factors for diabetic foot ulcers mortality and novel negative pressure combined with platelet-rich plasma therapy in the treatment of diabetic foot ulcers

Nanotechnology in cervical cancer immunotherapy: Therapeutic vaccines and adoptive cell therapy

C188-9, a specific inhibitor of STAT3 signaling, prevents thermal burn-induced skeletal muscle wasting in mice

The emerging roles of TLR and cGAS signaling in tumorigenesis and progression of ovarian cancer

Editorial: Purinergic signaling and neuroinflammation

A review of recent advances in exosomes and allergic rhinitis

The significance of glycolysis in tumor progression and its relationship with the tumor microenvironment